Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna ...

In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than one. The healthcare ...

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

A team of Chinese researchers has discovered a new bat coronavirus capable of infecting humans through the same receptor used ...

Lab experiments showed that the virus could infect human cells with high ACE2 levels, including models of human intestines ...

The lab finding does raise the possibility that this new bat virus could spread from animals to humans, researchers said in a ...

Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 ...

Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Moderna Inc. (NASDAQ:MRNA) reported a fourth-quarter EPS loss of $(2.91), missing the consensus of $(2.62), a turnaround from ...

An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...